This 'immunity-boosting' peptide may treat long COVID. But the FDA still has 1 major concern.
- Posted on July 22, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
This 'immunity-boosting' peptide may treat long COVID. But the FDA still has 1 major concern.
It’s approved in over 30 countries, just not the United States.
